Background: Insulin is an essential therapy for patients with type 1 diabetes mellitus (T1DM).
With the progression of the disease, many patients with T1DM may have an increased …

… one may further speculate that this also might be the case in the present study in lean
patients with Type 1 diabetes… for the treatment of patients with Type 1 diabetes. As such, it is a …

Objective To assess the efficacy and safety of dual sodium glucose cotransporter (SGLT) 1/2
inhibitor sotagliflozin in type 1 diabetes mellitus. Design Meta-analysis of randomised …

… This study evaluated the long-term safety and efficacy of dapagliflozin as an adjunct to
adjustable insulin in patients with type 1 diabetes and inadequate glycemic control. …

… NPH insulin regarding glycemic control in patients with type 1 diabetes. RESEARCH DESIGN
AND METHODS: A total of 333 type 1 diabetic patients were enrolled in this multinational …

… In this RCT in preschool- and school-aged children with type 1 diabetes, we found no
benefit of wearing a CGM sensor on glycemic control after a 26-week follow-up period, despite …

… the treatment of type 2 diabetes. We aimed to assess the efficacy and safety of dapagliflozin
as an add-on to adjustable insulin in patients with inadequately controlled type 1 diabetes. …

… Glycemic control is still frequently suboptimal in people with type 1 diabetes (1). Maintaining
strict … for type 2 diabetes show promise when added to insulin therapy in type 1 diabetes (3). …

Background Hypoglycaemia unawareness and severe hypoglycaemia can increase fear of
hypoglycaemia and the risk of subsequent hypoglycaemic events. We aimed to assess the …

… and hyperglycemia (1). Consequently, treatment of type 1 diabetes requires lifelong
insulin therapy to maintain normal blood glucose levels. Type 1 diabetes is associated with …